1-(3-trifluoromethylphenyl)piperazine has been researched along with Acute Liver Injury, Drug-Induced in 1 studies
1-(3-trifluoromethylphenyl)piperazine: acts as serotonin agonist; structure
1-(3-(trifluoromethyl)phenyl)piperazine : A N-arylpiperazine that is piperazine substituted by a 3-(trifluoromethyl)phenyl group at position 1. A serotonergic agonist used as a recreational drug.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arbo, MD | 1 |
| Melega, S | 1 |
| Stöber, R | 1 |
| Schug, M | 1 |
| Rempel, E | 1 |
| Rahnenführer, J | 1 |
| Godoy, P | 1 |
| Reif, R | 1 |
| Cadenas, C | 1 |
| de Lourdes Bastos, M | 1 |
| Carmo, H | 1 |
| Hengstler, JG | 1 |
1 other study available for 1-(3-trifluoromethylphenyl)piperazine and Acute Liver Injury, Drug-Induced
| Article | Year |
|---|---|
Hepatotoxicity of piperazine designer drugs: up-regulation of key enzymes of cholesterol and lipid biosynthesis.
Topics: Animals; Cell Survival; Cells, Cultured; Chemical and Drug Induced Liver Injury; Cholesterol; Design | 2016 |